Jeremy has over 6 years of experience in life sciences consulting, supporting biotech and pharma clients across functions, development stages, and the commercial lifecycle. Prior to joining Asymmetry Group, Jeremy worked at Lumanity (acquired Clarion Healthcare) as a Senior Consultant where he led a wide range of strategic engagements focused on improving patient outcomes and maximizing product impact.
Jeremy has led strategic initiatives in GTM strategy, commercial excellence, opportunity assessments, TPP testing, BD&L and strategic launch and brand planning. His experience spans across several therapeutic areas and modalities including cardiovascular, CNS, nephrology, respiratory, various rare diseases, and cell and gene therapies. Jeremy has partnered directly with commercial leadership on numerous occasions becoming a trusted thought partner and ensuring optimal delivery of actionable insights.
Jeremy holds an M.S. in Applied Economics from Boston College and a B.S. in Math & Economics from Saint Michael’s College.